Archive for ‘Beauté / Beauty’

November 18, 2013

Shire s’offre le spécialiste des maladies rares ViroPharma pour 4,2 milliards de dollars

Le laboratoire pharmaceutique britannique Shire va racheter l’américain ViroPharma, spécialisé dans les maladies rares, pour 4,2 milliards de dollars, a-t-il annoncé lundi dans un communiqué. ViroPharma commercialise en particulier le Cinryze contre l’angio-oedème héréditaire.

« Shire et ViroPharma annoncent aujourd’hui que leurs conseils d’administration ont approuvé à l’unanimité un accord de fusion dans le cadre duquel Shire va acquérir toutes les actions de la société spécialisée dans les maladies rares ViroPharma pour 50 dollars par titre, soit un montant total d’environ 4,2 milliards », a indiqué dans un communiqué Shire, société d’origine britannique cotée à Londres mais dont le siège est basé en Irlande. Le prix payé par Shire représente une prime de 27% par rapport au cours de ViroPharma vendredi.

Les deux groupes s’attendent à des synergies annuelles d’un montant de 150 millions de dollars d’ici 2015. « L’acquisition de ViroPharma va immédiatement bénéficier à Shire et est totalement cohérente avec notre clair objectif stratégique de renforcer notre portefeuille de (traitements contre les) maladies rares. Elle nous amène un nouveau produit pourvoyeur de croissance qui va augmenter nos perspectives de croissance déjà solides », a commenté le directeur général de Shire, Flemming Ornskov.

See on www.lesechos.fr

From Pharmaceutical Industry digital vision

Tags: ,
November 14, 2013

Walgreen and the Biggest Biotech Startup You’ve Never Heard Of (WAG)

Walgreen’s new partnership could change the way we think of pharmacies. – Eric Ho – Health Care

A potential blockbuster partnership between Walgreen  (NYSE: WAG  ) and stealth lab diagnostic biotechnology firm Theranos recently went quietly under the radar as retail pharmacy chains continue to expand their service offerings into new territories.

Walgreen, alongside national pharmacy cousins CVS (NYSE: CVS  ) and Rite Aid (NYSE:RAD  ) , has made big strides in adding services aimed at filling in the widening primary care gap. Innovations like in-store medical clinics, expanded immunization programs, and other care services  have paid off significantly for investors as share prices of all three major chains continue to see robust gains since the start of the year.

While the positive impact of these innovative services is likely to continue, it appears for the moment that the competing pharmacy chains have reached an equilibrium on new programs. Walgreens, CVS, and Rite Aid each performing similar services in an effort to match competitors in the fight over market share.

The billion-dollar question going into the future for this space is now: Who will roll out the next big thing in pharmacy?

Pharmacy or health clinic?
I believe the largely unnoticed Theranos-Walgreen partnership could provide a major opportunity for Walgreen to break away from the rest of the pack and change how pharmacies integrate into the health care model.

While the line between physicians’ clinics and pharmacies has blurred significantly in the last five years, pharmacies still lack a critical component in the clinical assessment of their patients: the ability to run blood tests to track health metrics and progress. Without this important piece of the puzzle, pharmacies ultimately rely on external sources and follow-up calls to piece together a patient’s story.

See on www.fool.com

From Pharmaceutical Industry digital vision

 

July 17, 2013

Climate Dress – CO2 sensing fashion – Climate Dress, Climate, Arduino, LilyPad, Alexandra, Forster-Rohner, Institute – talk2myShirt

There is a high probability the Climate Dress was made by Danish cooperation consisting of design studio Diffus, designer Tine

There is a high probability the Climate Dress was made by a Danish cooperation consisting of design studio Diffus, Danish designer Tine M. Jensen, Swiss embroidery company Forster-Rohner, the Danish research-company Alexandra Institute and finally the Danish School of Design. Sadly, the recently broken closed down climate conference COP15 did not come up with any significant agreement or result on addressing the arising problems CO2 has on pour climate, the Climate Dress might be the best thing to look for now. The Climate Dress is made of conductive embroidery and contains over hundred LEDs inserted into the embroidery. The twist on this dress: it includes a CO2 sensor which monitors the surrounding air for the CO2 level, send the data to a LilyPad Arduino which then visualizes the pollution level via LED light pattern on the dress. While the presentation of this functionality could have been done in a more ‘work-wear’ or other professional clothing item, alerting persons working in hazardous environments, I love the presentation in from of an fashionable dress which, to my opinion, is hammering home the message of CO2 and climate change more powerful than it would have been in work-wear

See on www.talk2myshirt.com

From Pharmaceutical Industry digital vision